{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:23:27Z","timestamp":1793917407748,"version":"4.8.0"},"reference-count":274,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030887","name":"Central Council for Research in Unani Medicine","doi-asserted-by":"publisher","award":["Grant No. 3-69\/2020- CCRUM\/Tech"],"award-info":[{"award-number":["Grant No. 3-69\/2020- CCRUM\/Tech"]}],"id":[{"id":"10.13039\/100030887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-025-00821-y","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T14:40:29Z","timestamp":1743691229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Multi-target approach to Alzheimer\u2019s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms"],"prefix":"10.1007","volume":"26","author":[{"given":"Kashif","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudassir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazura","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"issue":"2","key":"821_CR1","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","volume":"19","author":"A Gustavsson","year":"2023","unstructured":"Gustavsson A, Norton N, Fast T, Frolich L, Georges J, Holzapfel D, Kirabali T, Krolak-Salmon P, Rossini PM, Ferretti MT, Lanman L, Chadha AS, van der Flier WM (2023) Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimers Dement 19(2):658\u2013670","journal-title":"Alzheimers Dement"},{"issue":"8","key":"821_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/omi.2022.0067","volume":"26","author":"M Adnan","year":"2022","unstructured":"Adnan M, Koli S, Mohammad T, Siddiqui AJ, Patel M, Alshammari N, Bardakci F, Elasbali AM, Hassan MI (2022) Searching for novel anaplastic lymphoma kinase inhibitors: structure-guided screening of natural compounds for a tyrosine kinase therapeutic target in cancers. OMICS 26(8):461\u2013470","journal-title":"OMICS"},{"issue":"4","key":"821_CR3","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/biomedicines11041215","volume":"11","author":"A Surguchov","year":"2023","unstructured":"Surguchov A, Emamzadeh FN, Titova M, Surguchev AA (2023) Controversial properties of amyloidogenic proteins and peptides: new data in the COVID era. Biomedicines 11(4):1215","journal-title":"Biomedicines"},{"issue":"1","key":"821_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2010-1221","volume":"19","author":"MP Murphy","year":"2010","unstructured":"Murphy MP, LeVine H 3rd (2010) Alzheimer\u2019s disease and the amyloid-beta peptide. J Alzheimers Dis 19(1):311\u2013323","journal-title":"J Alzheimers Dis"},{"key":"821_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fnagi.2020.00265","volume":"12","author":"P d'Errico","year":"2020","unstructured":"d\u2019Errico P, Meyer-Luehmann M (2020) Mechanisms of pathogenic tau and abeta protein spreading in Alzheimer\u2019s disease. Front Aging Neurosci 12:265","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"821_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-021-00465-0","volume":"16","author":"MM Rahman","year":"2021","unstructured":"Rahman MM, Lendel C (2021) Extracellular protein components of amyloid plaques and their roles in Alzheimer\u2019s disease pathology. Mol Neurodegener 16(1):59","journal-title":"Mol Neurodegener"},{"key":"821_CR7","doi-asserted-by":"publisher","unstructured":"Prabha S, Choudhury A, Islam A, Thakur SC, Hassan MI (2025) Understanding of Alzheimer\u2019s disease pathophysiology for therapeutic implications of natural products as neuroprotective agents. Ageing Res Rev 102680. https:\/\/doi.org\/10.1016\/j.arr.2025.102680","DOI":"10.1016\/j.arr.2025.102680"},{"key":"821_CR8","doi-asserted-by":"publisher","unstructured":"Prabha S, Sajad M, Hasan GM, Islam A, Hassan MI, Thakur SC (2024) Recent advancement in understanding of Alzheimer\u2019s disease: risk factors, subtypes, and drug targets and potential therapeutics. Ageing Res Rev 102476. https:\/\/doi.org\/10.1016\/j.arr.2024.102476","DOI":"10.1016\/j.arr.2024.102476"},{"issue":"1","key":"821_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biom6010006","volume":"6","author":"G Simic","year":"2016","unstructured":"Simic G, Babic Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milosevic N, Bazadona D, Buee L, de Silva R, Di Giovanni G, Wischik C, Hof PR (2016) Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules 6(1):6","journal-title":"Biomolecules"},{"issue":"14","key":"821_CR10","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.3390\/ijms21145030","volume":"21","author":"E Vacchi","year":"2020","unstructured":"Vacchi E, Kaelin-Lang A, Melli G (2020) Tau and alpha synuclein synergistic effect in neurodegenerative diseases: when the periphery is the core. Int J Mol Sci 21(14):5030","journal-title":"Int J Mol Sci"},{"issue":"17","key":"821_CR11","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/cells11172728","volume":"11","author":"G Di Benedetto","year":"2022","unstructured":"Di Benedetto G, Burgaletto C, Bellanca CM, Munaf\u00f2 A, Bernardini R, Cantarella G (2022) Role of microglia and astrocytes in Alzheimer\u2019s disease: from neuroinflammation to Ca2+ homeostasis dysregulation. Cells 11(17):2728","journal-title":"Cells"},{"key":"821_CR12","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H (2022) Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol 13:856376","journal-title":"Front Immunol"},{"key":"821_CR13","doi-asserted-by":"publisher","first-page":"109420","DOI":"10.1016\/j.cellsig.2019.109420","volume":"64","author":"R Havekes","year":"2019","unstructured":"Havekes R, Heckman PRA, Wams EJ, Stasiukonyte N, Meerlo P, Eisel ULM (2019) Alzheimer\u2019s disease pathogenesis: the role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes. Cell Signal 64:109420","journal-title":"Cell Signal"},{"key":"821_CR14","doi-asserted-by":"publisher","unstructured":"Alzheimer's disease facts and figures (2020). Alzheimers Dement. https:\/\/doi.org\/10.1002\/alz.12068","DOI":"10.1002\/alz.12068"},{"key":"821_CR15","doi-asserted-by":"publisher","first-page":"101711","DOI":"10.1016\/j.nicl.2019.101711","volume":"22","author":"M Bruun","year":"2019","unstructured":"Bruun M, Koikkalainen J, Rhodius-Meester HFM, Baroni M, Gjerum L, van Gils M, Soininen H, Remes AM, Hartikainen P, Waldemar G, Mecocci P, Barkhof F, Pijnenburg Y, van der Flier WM, Hasselbalch SG, Lotjonen J, Frederiksen KS (2019) Detecting frontotemporal dementia syndromes using MRI biomarkers. Neuroimage Clin 22:101711","journal-title":"Neuroimage Clin"},{"key":"821_CR16","unstructured":"Kumar A, Sidhu J, Lui F, Tsao JW, Doerr C. (2025) Alzheimer disease (Nursing). In: StatPearls.\u00a0StatPearls Publishing, Treasure Island\u00a0"},{"issue":"2","key":"821_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tins.2022.11.006","volume":"46","author":"KM Igarashi","year":"2023","unstructured":"Igarashi KM (2023) Entorhinal cortex dysfunction in Alzheimer\u2019s disease. Trends Neurosci 46(2):124\u2013136","journal-title":"Trends Neurosci"},{"issue":"21","key":"821_CR18","doi-asserted-by":"publisher","first-page":"e2132","DOI":"10.1212\/WNL.0000000000200256","volume":"98","author":"A McGirr","year":"2022","unstructured":"McGirr A, Nathan S, Ghahremani M, Gill S, Smith EE, Ismail Z (2022) Progression to dementia or reversion to normal cognition in mild cognitive impairment as a function of late-onset neuropsychiatric symptoms. Neurology 98(21):e2132\u2013e2139","journal-title":"Neurology"},{"issue":"2","key":"821_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/j.2051-5545.2008.tb00159.x","volume":"7","author":"PB Rosenberg","year":"2008","unstructured":"Rosenberg PB, Lyketsos C (2008) Mild cognitive impairment: searching for the prodrome of Alzheimer\u2019s disease. World Psych 7(2):72\u201378","journal-title":"World Psych"},{"issue":"3","key":"821_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/antiox11030554","volume":"11","author":"SNA Bukhari","year":"2022","unstructured":"Bukhari SNA (2022) Dietary polyphenols as therapeutic intervention for Alzheimer\u2019s disease: a mechanistic insight. Antioxidants (Basel) 11(3):554","journal-title":"Antioxidants (Basel)"},{"issue":"21","key":"821_CR21","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.3390\/nu14214564","volume":"14","author":"O Stefaniak","year":"2022","unstructured":"Stefaniak O, Dobrzy\u0144ska M, Drzyma\u0142a-Czy\u017c S, Przys\u0142awski J (2022) Diet in the prevention of Alzheimer\u2019s disease: current knowledge and future research requirements. Nutrients 14(21):4564","journal-title":"Nutrients"},{"key":"821_CR22","doi-asserted-by":"publisher","first-page":"S422","DOI":"10.1093\/advances\/nmz081","volume":"10","author":"S Rajaram","year":"2019","unstructured":"Rajaram S, Jones J, Lee GJ (2019) Plant-based dietary patterns, plant foods, and age-related cognitive decline. Adv Nutr 10:S422\u2013S436","journal-title":"Adv Nutr"},{"issue":"4","key":"821_CR23","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2174\/1570159X14666161026151545","volume":"15","author":"I Figueira","year":"2017","unstructured":"Figueira I, Menezes R, Macedo D, Costa I, Dos Santos CN (2017) Polyphenols beyond barriers: a glimpse into the brain. Curr Neuropharmacol 15(4):562\u2013594","journal-title":"Curr Neuropharmacol"},{"key":"821_CR24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jff.2015.06.018","volume":"18","author":"F Shahidi","year":"2015","unstructured":"Shahidi F, Ambigaipalan P (2015) Phenolics and polyphenolics in foods, beverages and spices: antioxidant activity and health effects \u2013 a review. J Funct Foods 18:820\u2013897","journal-title":"J Funct Foods"},{"key":"821_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fnut.2016.00031","volume":"3","author":"M Caruana","year":"2016","unstructured":"Caruana M, Cauchi R, Vassallo N (2016) Putative role of red wine polyphenols against brain pathology in Alzheimer\u2019s and Parkinson\u2019s disease. Front Nutr 3:31","journal-title":"Front Nutr"},{"key":"821_CR26","doi-asserted-by":"publisher","first-page":"619024","DOI":"10.3389\/fphar.2020.619024","volume":"11","author":"MH Rahman","year":"2020","unstructured":"Rahman MH, Akter R, Bhattacharya T, Abdel-Daim MM, Alkahtani S, Arafah MW, Al-Johani NS, Alhoshani NM, Alkeraishan N, Alhenaky A, Abd-Elkader OH, El-Seedi HR, Kaushik D, Mittal V (2020) Resveratrol and neuroprotection: impact and its therapeutic potential in Alzheimer\u2019s disease. Front Pharmacol 11:619024","journal-title":"Front Pharmacol"},{"issue":"4","key":"821_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/nu11040756","volume":"11","author":"HT Phan","year":"2019","unstructured":"Phan HT, Samarat K, Takamura Y, Azo-Oussou AF, Nakazono Y, Vestergaard MDC (2019) Polyphenols modulate alzheimer\u2019s amyloid beta aggregation in a structure-dependent manner. Nutrients 11(4):756","journal-title":"Nutrients"},{"issue":"4","key":"821_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.2174\/1570159X20666221010113812","volume":"21","author":"ER Kabir","year":"2023","unstructured":"Kabir ER, Chowdhury NM, Yasmin H, Kabir MT, Akter R, Perveen A, Ashraf GM, Akter S, Rahman MH, Sweilam SH (2023) Unveiling the potential of polyphenols as anti-amyloid molecules in Alzheimer\u2019s disease. Curr Neuropharmacol 21(4):787\u2013807","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"821_CR29","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.3390\/ijms21103561","volume":"21","author":"H Kobayashi","year":"2020","unstructured":"Kobayashi H, Murata M, Kawanishi S, Oikawa S (2020) Polyphenols with anti-amyloid \u03b2 aggregation show potential risk of toxicity via pro-oxidant properties. Int J Mol Sci 21(10):3561","journal-title":"Int J Mol Sci"},{"issue":"12","key":"821_CR30","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.3390\/molecules24122316","volume":"24","author":"Q Zheng","year":"2019","unstructured":"Zheng Q, Kebede MT, Kemeh MM, Islam S, Lee B, Bleck SD, Wurfl LA, Lazo ND (2019) Inhibition of the self-assembly of A\u03b2 and of tau by polyphenols: mechanistic studies. Molecules 24(12):2316","journal-title":"Molecules"},{"key":"821_CR31","doi-asserted-by":"publisher","first-page":"7432797","DOI":"10.1155\/2016\/7432797","volume":"2016","author":"T Hussain","year":"2016","unstructured":"Hussain T, Tan B, Yin Y, Blachier F, Tossou MC, Rahu N (2016) Oxidative stress and inflammation: what polyphenols can do for us? Oxid Med Cell Longev 2016:7432797","journal-title":"Oxid Med Cell Longev"},{"issue":"11","key":"821_CR32","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/nu10111618","volume":"10","author":"N Yahfoufi","year":"2018","unstructured":"Yahfoufi N, Alsadi N, Jambi M, Matar C (2018) The immunomodulatory and anti-inflammatory role of polyphenols. Nutrients 10(11):1618","journal-title":"Nutrients"},{"issue":"1","key":"821_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s10753-016-0477-1","volume":"40","author":"M Boshtam","year":"2017","unstructured":"Boshtam M, Asgary S, Kouhpayeh S, Shariati L, Khanahmad H (2017) Aptamers against pro- and anti-inflammatory cytokines: a review. Inflammation 40(1):340\u2013349","journal-title":"Inflammation"},{"issue":"5","key":"821_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/ijmm.2023.5314","volume":"52","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q, Yang L, Xu P, Jiang X (2023) Inflammatory signaling pathways in the treatment of Alzheimer\u2019s disease with inhibitors, natural products and metabolites. Int J Mol Med 52(5):111","journal-title":"Int J Mol Med"},{"key":"821_CR35","first-page":"23","volume":"10","author":"F Moosavi","year":"2016","unstructured":"Moosavi F, Hosseini R, Saso L, Firuzi O (2016) Modulation of neurotrophic signaling pathways by polyphenols. Drug Des Devel Ther 10:23\u201342","journal-title":"Drug Des Devel Ther"},{"issue":"14","key":"821_CR36","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.3390\/molecules28145415","volume":"28","author":"RA Arias-S\u00e1nchez","year":"2023","unstructured":"Arias-S\u00e1nchez RA, Torner L, Fenton Navarro B (2023) Polyphenols and neurodegenerative diseases: potential effects and mechanisms of neuroprotection. Molecules 28(14):5415","journal-title":"Molecules"},{"key":"821_CR37","doi-asserted-by":"publisher","first-page":"1019942","DOI":"10.3389\/fnagi.2022.1019942","volume":"14","author":"F El Gaamouch","year":"2022","unstructured":"El Gaamouch F, Chen F, Ho L, Lin HY, Yuan C, Wong J, Wang J (2022) Benefits of dietary polyphenols in Alzheimer\u2019s disease. Front Aging Neurosci 14:1019942","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"821_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/ijms22010196","volume":"22","author":"U Shabbir","year":"2020","unstructured":"Shabbir U, Rubab M, Tyagi A, Oh DH (2020) Curcumin and its derivatives as theranostic agents in Alzheimer\u2019s disease: the implication of nanotechnology. Int J Mol Sci 22(1):196","journal-title":"Int J Mol Sci"},{"issue":"10","key":"821_CR39","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.3390\/nu13103652","volume":"13","author":"MC Lu","year":"2021","unstructured":"Lu MC, Lee IT, Hong LZ, Ben-Arie E, Lin YH, Lin WT, Kao PY, Yang MD, Chan YC (2021) Coffeeberry activates the CaMKII\/CREB\/BDNF pathway, normalizes autophagy and apoptosis signaling in nonalcoholic fatty liver rodent model. Nutrients 13(10):3652","journal-title":"Nutrients"},{"issue":"3","key":"821_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ntt.2004.02.006","volume":"26","author":"KP Das","year":"2004","unstructured":"Das KP, Freudenrich TM, Mundy WR (2004) Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol Teratol 26(3):397\u2013406","journal-title":"Neurotoxicol Teratol"},{"issue":"4","key":"821_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4161\/cam.5.4.16986","volume":"5","author":"ZD Zhou","year":"2011","unstructured":"Zhou ZD, Chan CH, Ma QH, Xu XH, Xiao ZC, Tan EK (2011) The roles of amyloid precursor protein (APP) in neurogenesis: implications to pathogenesis and therapy of Alzheimer disease. Cell Adh Migr 5(4):280\u2013292","journal-title":"Cell Adh Migr"},{"issue":"1","key":"821_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jnc.14122","volume":"143","author":"LJ Sosa","year":"2017","unstructured":"Sosa LJ, Caceres A, Dupraz S, Oksdath M, Quiroga S, Lorenzo A (2017) The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system. J Neurochem 143(1):11\u201329","journal-title":"J Neurochem"},{"key":"821_CR43","doi-asserted-by":"publisher","first-page":"969547","DOI":"10.3389\/fcell.2022.969547","volume":"10","author":"G Pfundstein","year":"2022","unstructured":"Pfundstein G, Nikonenko AG, Sytnyk V (2022) Amyloid precursor protein (APP) and amyloid beta (Abeta) interact with cell adhesion molecules: implications in Alzheimer\u2019s disease and normal physiology. Front Cell Dev Biol 10:969547","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"821_CR44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3934\/Neuroscience.2019.4.273","volume":"6","author":"KV Nguyen","year":"2019","unstructured":"Nguyen KV (2019) Beta-amyloid precursor protein (APP) and the human diseases. AIMS Neurosci 6(4):273\u2013281","journal-title":"AIMS Neurosci"},{"issue":"7","key":"821_CR45","doi-asserted-by":"publisher","first-page":"e41776","DOI":"10.1371\/journal.pone.0041776","volume":"7","author":"SK Pirooznia","year":"2012","unstructured":"Pirooznia SK, Sarthi J, Johnson AA, Toth MS, Chiu K, Koduri S, Elefant F (2012) Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a drosophila Alzheimer\u2019s disease model. PLoS ONE 7(7):e41776","journal-title":"PLoS ONE"},{"issue":"5527","key":"821_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1126\/science.1058783","volume":"293","author":"X Cao","year":"2001","unstructured":"Cao X, Sudhof TC (2001) A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293(5527):115\u2013120","journal-title":"Science"},{"issue":"8","key":"821_CR47","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s12264-022-00985-9","volume":"39","author":"W Cai","year":"2023","unstructured":"Cai W, Li L, Sang S, Pan X, Zhong C (2023) Physiological roles of beta-amyloid in regulating synaptic function: implications for AD pathophysiology. Neurosci Bull 39(8):1289\u20131308","journal-title":"Neurosci Bull"},{"issue":"1","key":"821_CR48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.14336\/AD.2023.0524","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Chen J-S, Li S, Zhang F, Deng J, Zeng L-H, Tan J (2024) Amyloid precursor protein: a regulatory hub in Alzheimer\u2019s disease. Aging Dis 15(1):201","journal-title":"Aging Dis"},{"key":"821_CR49","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O'Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204","journal-title":"Annu Rev Neurosci"},{"issue":"11","key":"821_CR50","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1523\/JNEUROSCI.5170-04.2005","volume":"25","author":"JD Fryer","year":"2005","unstructured":"Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM (2005) Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci 25(11):2803\u20132810","journal-title":"J Neurosci"},{"issue":"24","key":"821_CR51","doi-asserted-by":"publisher","first-page":"15871","DOI":"10.3390\/ijms232415871","volume":"23","author":"P Abondio","year":"2022","unstructured":"Abondio P, Bruno F, Bruni AC, Luiselli D (2022) Rare amyloid precursor protein point mutations recapitulate worldwide migration and admixture in healthy individuals: implications for the study of neurodegeneration. Int J Mol Sci 23(24):15871","journal-title":"Int J Mol Sci"},{"issue":"5","key":"821_CR52","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1194\/jlr.R075481","volume":"58","author":"TV Huynh","year":"2017","unstructured":"Huynh TV, Davis AA, Ulrich JD, Holtzman DM (2017) Apolipoprotein E and Alzheimer\u2019s disease: the influence of apolipoprotein E on amyloid-beta and other amyloidogenic proteins. J Lipid Res 58(5):824\u2013836","journal-title":"J Lipid Res"},{"issue":"10","key":"821_CR53","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T, Masters CL, Cho M, Lannfelt L, Cummings JL, Vergallo A (2021) The amyloid-beta pathway in Alzheimer\u2019s disease. Mol Psychiatry 26(10):5481\u20135503","journal-title":"Mol Psychiatry"},{"key":"821_CR54","doi-asserted-by":"publisher","first-page":"642623","DOI":"10.3389\/fcell.2021.642623","volume":"9","author":"M Gonzalez-Garcia","year":"2021","unstructured":"Gonzalez-Garcia M, Fusco G, De Simone A (2021) Membrane interactions and toxicity by misfolded protein oligomers. Front Cell Dev Biol 9:642623","journal-title":"Front Cell Dev Biol"},{"key":"821_CR55","doi-asserted-by":"publisher","first-page":"845185","DOI":"10.3389\/fphar.2022.845185","volume":"13","author":"T Liang","year":"2022","unstructured":"Liang T, Zhang Y, Wu S, Chen Q, Wang L (2022) The role of NLRP3 inflammasome in Alzheimer\u2019s disease and potential therapeutic targets. Front Pharmacol 13:845185","journal-title":"Front Pharmacol"},{"key":"821_CR56","doi-asserted-by":"publisher","first-page":"204062232210816","DOI":"10.1177\/20406223221081605","volume":"13","author":"FL Vecchio","year":"2022","unstructured":"Vecchio FL, Bisceglia P, Imbimbo BP, Lozupone M, Latino RR, Resta E, Leone M, Solfrizzi V, Greco A, Daniele A, Watling M, Panza F, Seripa D (2022) Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer\u2019s disease? Ther Adv Chronic Dis 13:20406223221081604","journal-title":"Ther Adv Chronic Dis"},{"issue":"17","key":"821_CR57","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.3390\/ijms21176336","volume":"21","author":"MF Lanfranco","year":"2020","unstructured":"Lanfranco MF, Ng CA, Rebeck GW (2020) ApoE lipidation as a therapeutic target in Alzheimer\u2019s disease. Int J Mol Sci 21(17):6336","journal-title":"Int J Mol Sci"},{"issue":"Pt A","key":"821_CR58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang Y, Mahley RW (2014) Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol Dis 72(Pt A):3\u201312","journal-title":"Neurobiol Dis"},{"key":"821_CR59","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2013.12.016","volume":"64","author":"LA Johnson","year":"2014","unstructured":"Johnson LA, Olsen RH, Merkens LS, DeBarber A, Steiner RD, Sullivan PM, Maeda N, Raber J (2014) Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol Dis 64:150\u2013162","journal-title":"Neurobiol Dis"},{"issue":"5","key":"821_CR60","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2217\/17460875.3.5.505","volume":"3","author":"EP de Chaves","year":"2008","unstructured":"de Chaves EP, Narayanaswami V (2008) Apolipoprotein E and cholesterol in aging and disease in the brain. Future Lipidol 3(5):505\u2013530","journal-title":"Future Lipidol"},{"issue":"1","key":"821_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-020-00413-4","volume":"15","author":"Z Li","year":"2020","unstructured":"Li Z, Shue F, Zhao N, Shinohara M, Bu G (2020) APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease. Mol Neurodegener 15(1):63","journal-title":"Mol Neurodegener"},{"issue":"2","key":"821_CR62","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","volume":"12","author":"BR Troutwine","year":"2022","unstructured":"Troutwine BR, Hamid L, Lysaker CR, Strope TA, Wilkins HM (2022) Apolipoprotein E and Alzheimer\u2019s disease. Acta Pharm Sin B 12(2):496\u2013510","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"821_CR63","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72","journal-title":"Mol Neurodegener"},{"issue":"7","key":"821_CR64","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/cells9071717","volume":"9","author":"JA Rodr\u00edguez-G\u00f3mez","year":"2020","unstructured":"Rodr\u00edguez-G\u00f3mez JA, Kavanagh E, Engskog-Vlachos P, Engskog MK, Herrera AJ, Espinosa-Oliva AM, Joseph B, Hajji N, Venero JL, Burguillos MA (2020) Microglia: agents of the CNS pro-inflammatory response. Cells 9(7):1717","journal-title":"Cells"},{"key":"821_CR65","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fncel.2019.00181","volume":"13","author":"C Muth","year":"2019","unstructured":"Muth C, Hartmann A, Sepulveda-Falla D, Glatzel M, Krasemann S (2019) Phagocytosis of apoptotic cells is specifically upregulated in ApoE4 expressing microglia in vitro. Front Cell Neurosci 13:181","journal-title":"Front Cell Neurosci"},{"key":"821_CR66","doi-asserted-by":"publisher","first-page":"630502","DOI":"10.3389\/fnins.2021.630502","volume":"15","author":"MA Husain","year":"2021","unstructured":"Husain MA, Laurent B, Plourde M (2021) APOE and Alzheimer\u2019s disease: from lipid transport to physiopathology and therapeutics. Front Neurosci 15:630502","journal-title":"Front Neurosci"},{"key":"821_CR67","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnagi.2020.00150","volume":"12","author":"HN Yassine","year":"2020","unstructured":"Yassine HN, Finch CE (2020) APOE alleles and diet in brain aging and Alzheimer\u2019s disease. Front Aging Neurosci 12:150","journal-title":"Front Aging Neurosci"},{"key":"821_CR68","doi-asserted-by":"publisher","first-page":"838436","DOI":"10.3389\/fnagi.2022.838436","volume":"14","author":"KE Foley","year":"2022","unstructured":"Foley KE, Hewes AA, Garceau DT, Kotredes KP, Carter GW, Sasner M, Howell GR (2022) The APOE (epsilon3\/epsilon4) genotype drives distinct gene signatures in the cortex of young mice. Front Aging Neurosci 14:838436","journal-title":"Front Aging Neurosci"},{"key":"821_CR69","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO (2008) APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neurol 8:9","journal-title":"BMC Neurol"},{"issue":"2","key":"821_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106\u2013118","journal-title":"Nat Rev Neurol"},{"key":"821_CR71","first-page":"355","volume":"145","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG (2017) Tauopathies. Handb Clin Neurol 145:355\u2013368","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"821_CR72","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/cells11060923","volume":"11","author":"F Pe\u00f1a-Ortega","year":"2022","unstructured":"Pe\u00f1a-Ortega F, Robles-G\u00f3mez \u00c1A, Xolalpa-Cueva L (2022) Microtubules as regulators of neural network shape and function: focus on excitability, plasticity and memory. Cells 11(6):923","journal-title":"Cells"},{"issue":"23","key":"821_CR73","doi-asserted-by":"publisher","first-page":"15383","DOI":"10.3390\/ijms232315383","volume":"23","author":"A Corsi","year":"2022","unstructured":"Corsi A, Bombieri C, Valenti MT, Romanelli MG (2022) Tau isoforms: gaining insight into MAPT alternative splicing. Int J Mol Sci 23(23):15383","journal-title":"Int J Mol Sci"},{"key":"821_CR74","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1750-1326-3-8","volume":"3","author":"F Liu","year":"2008","unstructured":"Liu F, Gong CX (2008) Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 3:8","journal-title":"Mol Neurodegener"},{"key":"821_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fncel.2020.00019","volume":"14","author":"D Toral-Rios","year":"2020","unstructured":"Toral-Rios D, Pichardo-Rojas PS, Alonso-Vanegas M, Campos-Pena V (2020) GSK3beta and tau protein in Alzheimer\u2019s disease and epilepsy. Front Cell Neurosci 14:19","journal-title":"Front Cell Neurosci"},{"key":"821_CR76","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2014.00232","volume":"6","author":"JF Castro-Alvarez","year":"2014","unstructured":"Castro-Alvarez JF, Uribe-Arias SA, Mejia-Raigosa D, Cardona-Gomez GP (2014) Cyclin-dependent kinase 5, a node protein in diminished tauopathy: a systems biology approach. Front Aging Neurosci 6:232","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"821_CR77","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3233\/JAD-2011-110320","volume":"26","author":"C Ploia","year":"2011","unstructured":"Ploia C, Antoniou X, Sclip A, Grande V, Cardinetti D, Colombo A, Canu N, Benussi L, Ghidoni R, Forloni G, Borsello T (2011) JNK plays a key role in tau hyperphosphorylation in Alzheimer\u2019s disease models. J Alzheimers Dis 26(2):315\u2013329","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"821_CR78","doi-asserted-by":"publisher","first-page":"666","DOI":"10.2174\/156720511796717195","volume":"8","author":"A Boutajangout","year":"2011","unstructured":"Boutajangout A, Sigurdsson EM, Krishnamurthy PK (2011) Tau as a therapeutic target for Alzheimer\u2019s disease. Curr Alzheimer Res 8(6):666\u2013677","journal-title":"Curr Alzheimer Res"},{"key":"821_CR79","doi-asserted-by":"publisher","first-page":"101924","DOI":"10.1016\/j.arr.2023.101924","volume":"87","author":"S Khan","year":"2023","unstructured":"Khan S, Hassan MI, Shahid M, Islam A (2023) Nature\u2019s toolbox against tau aggregation: an updated review of current research. Ageing Res Rev 87:101924","journal-title":"Ageing Res Rev"},{"issue":"102113","key":"821_CR80","first-page":"31","volume":"92","author":"T Khan","year":"2023","unstructured":"Khan T, Waseem R, Shahid M, Ansari J, Ahanger IA, Hassan I, Islam A (2023) Recent advancement in therapeutic strategies for Alzheimer\u2019s disease: insights from clinical trials. Ageing Res Rev 92(102113):31","journal-title":"Ageing Res Rev"},{"issue":"3","key":"821_CR81","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.3390\/ijms15034671","volume":"15","author":"A Mietelska-Porowska","year":"2014","unstructured":"Mietelska-Porowska A, Wasik U, Goras M, Filipek A, Niewiadomska G (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15(3):4671\u20134713","journal-title":"Int J Mol Sci"},{"issue":"6","key":"821_CR82","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41380-023-02113-z","volume":"28","author":"N Basheer","year":"2023","unstructured":"Basheer N, Smolek T, Hassan I, Liu F, Iqbal K, Zilka N, Novak P (2023) Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials. Mol Psychiatry 28(6):2197\u20132214","journal-title":"Mol Psychiatry"},{"issue":"12","key":"821_CR83","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2174\/1568026620666200106125910","volume":"20","author":"AA Turab Naqvi","year":"2020","unstructured":"Turab Naqvi AA, Hasan GM, Hassan MI (2020) Targeting tau hyperphosphorylation via kinase inhibition: strategy to address Alzheimer\u2019s disease. Curr Top Med Chem 20(12):1059\u20131073","journal-title":"Curr Top Med Chem"},{"key":"821_CR84","doi-asserted-by":"publisher","first-page":"600084","DOI":"10.3389\/fnmol.2020.600084","volume":"13","author":"A Hector","year":"2020","unstructured":"Hector A, Brouillette J (2020) Hyperactivity induced by soluble amyloid-beta oligomers in the early stages of Alzheimer\u2019s disease. Front Mol Neurosci 13:600084","journal-title":"Front Mol Neurosci"},{"issue":"17","key":"821_CR85","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1016\/j.jmb.2020.05.027","volume":"432","author":"SJ Pollack","year":"2020","unstructured":"Pollack SJ, Trigg J, Khanom T, Biasetti L, Marshall KE, Al-Hilaly YK, Rickard JE, Harrington CR, Wischik CM, Serpell LC (2020) Paired helical filament-forming region of tau (297\u2013391) influences endogenous tau protein and accumulates in acidic compartments in human neuronal cells. J Mol Biol 432(17):4891\u20134907","journal-title":"J Mol Biol"},{"issue":"1","key":"821_CR86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/bpa.12902","volume":"31","author":"DT Ohm","year":"2021","unstructured":"Ohm DT, Fought AJ, Martersteck A, Coventry C, Sridhar J, Gefen T, Weintraub S, Bigio E, Mesulam MM, Rogalski E, Geula C (2021) Accumulation of neurofibrillary tangles and activated microglia is associated with lower neuron densities in the aphasic variant of Alzheimer\u2019s disease. Brain Pathol 31(1):189\u2013204","journal-title":"Brain Pathol"},{"key":"821_CR87","doi-asserted-by":"publisher","first-page":"1201982","DOI":"10.3389\/fnagi.2023.1201982","volume":"15","author":"J Miao","year":"2023","unstructured":"Miao J, Ma H, Yang Y, Liao Y, Lin C, Zheng J, Yu M, Lan J (2023) Microglia in Alzheimer\u2019s disease: pathogenesis, mechanisms, and therapeutic potentials. Front Aging Neurosci 15:1201982","journal-title":"Front Aging Neurosci"},{"key":"821_CR88","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3389\/fimmu.2019.01668","volume":"10","author":"P Gervois","year":"2019","unstructured":"Gervois P, Lambrichts I (2019) The emerging role of triggering receptor expressed on myeloid cells 2 as a target for immunomodulation in ischemic stroke. Front Immunol 10:1668","journal-title":"Front Immunol"},{"issue":"10","key":"821_CR89","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.3390\/ijms24108626","volume":"24","author":"F La Rosa","year":"2023","unstructured":"La Rosa F, Agostini S, Piancone F, Marventano I, Hernis A, Fenoglio C, Galimberti D, Scarpini E, Saresella M, Clerici M (2023) TREM2 expression and amyloid-beta phagocytosis in Alzheimer\u2019s disease. Int J Mol Sci 24(10):8626","journal-title":"Int J Mol Sci"},{"issue":"2","key":"821_CR90","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.burns.2012.07.010","volume":"39","author":"AA Mohammadi","year":"2013","unstructured":"Mohammadi AA, Jafari SMS, Kiasat M, Tavakkolian AR, Imani MT, Ayaz M, Tolide-Ie HR (2013) Effect of fresh human amniotic membrane dressing on graft take in patients with chronic burn wounds compared with conventional methods. Burns 39(2):349\u2013353","journal-title":"Burns"},{"issue":"4","key":"821_CR91","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/femsre\/fuu010","volume":"39","author":"H Neuman","year":"2015","unstructured":"Neuman H, Debelius JW, Knight R, Koren O (2015) Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbiol Rev 39(4):509\u2013521","journal-title":"FEMS Microbiol Rev"},{"issue":"12","key":"821_CR92","doi-asserted-by":"publisher","first-page":"e405","DOI":"10.1038\/emm.2017.200","volume":"49","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Li X, Huang T, Jiang LL, Tan Z, Zhang M, Cheng IH, Wang X, Bu G, Zhang YW, Wang Q, Xu H (2017) Intracellular trafficking of TREM2 is regulated by presenilin 1. Exp Mol Med 49(12):e405","journal-title":"Exp Mol Med"},{"key":"821_CR93","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnagi.2017.00204","volume":"9","author":"L Zhong","year":"2017","unstructured":"Zhong L, Zhang ZL, Li X, Liao C, Mou P, Wang T, Wang Z, Wang Z, Wei M, Xu H, Bu G, Chen XF (2017) TREM2\/DAP12 complex regulates inflammatory responses in microglia via the JNK signaling pathway. Front Aging Neurosci 9:204","journal-title":"Front Aging Neurosci"},{"key":"821_CR94","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2018.00206","volume":"12","author":"H Konishi","year":"2018","unstructured":"Konishi H, Kiyama H (2018) Microglial TREM2\/DAP12 signaling: a double-edged sword in neural diseases. Front Cell Neurosci 12:206","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"821_CR95","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M (2023) The biology of TREM receptors. Nat Rev Immunol 23(9):580\u2013594","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"821_CR96","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","volume":"23","author":"SC Jin","year":"2014","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, Norton JB, Hsu S, Harari O, Cai Y, Bertelsen S, Goate AM, Cruchaga C (2014) Coding variants in TREM2 increase risk for Alzheimer\u2019s disease. Hum Mol Genet 23(21):5838\u20135846","journal-title":"Hum Mol Genet"},{"issue":"1","key":"821_CR97","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-018-0280-6","volume":"13","author":"X Xiang","year":"2018","unstructured":"Xiang X, Piers TM, Wefers B, Zhu K, Mallach A, Brunner B, Kleinberger G, Song W, Colonna M, Herms J, Wurst W, Pocock JM, Haass C (2018) The Trem2 R47H Alzheimer\u2019s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans. Mol Neurodegener 13(1):49","journal-title":"Mol Neurodegener"},{"issue":"1","key":"821_CR98","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13195-020-00709-z","volume":"12","author":"H Hall-Roberts","year":"2020","unstructured":"Hall-Roberts H, Agarwal D, Obst J, Smith TB, Monzon-Sandoval J, Di Daniel E, Webber C, James WS, Mead E, Davis JB, Cowley SA (2020) TREM2 Alzheimer\u2019s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages. Alzheimers Res Ther 12(1):151","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"821_CR99","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z (2020) TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease. J Neuroinflammation 17(1):204","journal-title":"J Neuroinflammation"},{"key":"821_CR100","doi-asserted-by":"publisher","first-page":"834697","DOI":"10.3389\/fnagi.2021.834697","volume":"13","author":"GC Brown","year":"2022","unstructured":"Brown GC, St George-Hyslop P (2022) Does soluble TREM2 protect against Alzheimer\u2019s disease? Front Aging Neurosci 13:834697","journal-title":"Front Aging Neurosci"},{"key":"821_CR101","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1750-1326-9-48","volume":"9","author":"S Tu","year":"2014","unstructured":"Tu S, Okamoto S, Lipton SA, Xu H (2014) Oligomeric abeta-induced synaptic dysfunction in Alzheimer\u2019s disease. Mol Neurodegener 9:48","journal-title":"Mol Neurodegener"},{"issue":"6","key":"821_CR102","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli R, Fedele E (2017) The amyloid cascade hypothesis in Alzheimer\u2019s disease: it\u2019s time to change our mind. Curr Neuropharmacol 15(6):926\u2013935","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"821_CR103","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1021\/acscentsci.3c00592","volume":"10","author":"AG Kreutzer","year":"2024","unstructured":"Kreutzer AG, Parrocha CMT, Haerianardakani S, Guaglianone G, Nguyen JT, Diab MN, Yong W, Perez-Rosendahl M, Head E, Nowick JS (2024) Antibodies raised against an abeta oligomer mimic recognize pathological features in Alzheimer\u2019s disease and associated amyloid-disease brain tissue. ACS Cent Sci 10(1):104\u2013121","journal-title":"ACS Cent Sci"},{"issue":"5","key":"821_CR104","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s12250-019-00124-1","volume":"34","author":"C Kong","year":"2019","unstructured":"Kong C, Xie H, Gao Z, Shao M, Li H, Shi R, Cai L, Gao S, Sun T, Li C (2019) Binding between prion protein and abeta oligomers contributes to the pathogenesis of Alzheimer\u2019s disease. Virol Sin 34(5):475\u2013488","journal-title":"Virol Sin"},{"key":"821_CR105","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/bs.apha.2017.09.007","volume":"82","author":"AH Brody","year":"2018","unstructured":"Brody AH, Strittmatter SM (2018) Synaptotoxic signaling by amyloid beta oligomers in alzheimer\u2019s disease through prion protein and mGluR5. Adv Pharmacol 82:293\u2013323","journal-title":"Adv Pharmacol"},{"issue":"20","key":"821_CR106","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.3390\/ijms21207452","volume":"21","author":"VN Bukke","year":"2020","unstructured":"Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T (2020) The dual role of glutamatergic neurotransmission in Alzheimer\u2019s disease: from pathophysiology to pharmacotherapy. Int J Mol Sci 21(20):7452","journal-title":"Int J Mol Sci"},{"issue":"5","key":"821_CR107","doi-asserted-by":"publisher","first-page":"a024075","DOI":"10.1101\/cshperspect.a024075","volume":"7","author":"LM Smith","year":"2017","unstructured":"Smith LM, Strittmatter SM (2017) Binding sites for amyloid-\u03b2 oligomers and synaptic toxicity. Cold Spring Harb Perspect Med 7(5):a024075","journal-title":"Cold Spring Harb Perspect Med"},{"key":"821_CR108","doi-asserted-by":"publisher","first-page":"728571","DOI":"10.5402\/2012\/728571","volume":"2012","author":"A Ferreira","year":"2012","unstructured":"Ferreira A (2012) Calpain dysregulation in Alzheimer\u2019s disease. ISRN Biochem 2012:728571","journal-title":"ISRN Biochem"},{"key":"821_CR109","doi-asserted-by":"publisher","first-page":"1235163","DOI":"10.3389\/fvets.2023.1235163","volume":"10","author":"E Metwally","year":"2023","unstructured":"Metwally E, Al-Abbadi HA, Hussain T, Murtaza G, Abdellatif AM, Ahmed MF (2023) Calpain signaling: from biology to therapeutic opportunities in neurodegenerative disorders. Front Vet Sci 10:1235163","journal-title":"Front Vet Sci"},{"key":"821_CR110","doi-asserted-by":"publisher","first-page":"964075","DOI":"10.3389\/fcell.2022.964075","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, Jiang X, Ma L, Wei W, Li Z, Chang S, Wen J, Sun J, Li H (2022) Role of abeta in Alzheimer\u2019s-related synaptic dysfunction. Front Cell Dev Biol 10:964075","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"821_CR111","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/biom12060785","volume":"12","author":"HL Zhang","year":"2022","unstructured":"Zhang HL, Wang XC, Liu R (2022) Zinc in regulating protein kinases and phosphatases in neurodegenerative diseases. Biomolecules 12(6):785","journal-title":"Biomolecules"},{"key":"821_CR112","first-page":"796024","volume":"2012","author":"MS Wolfe","year":"2012","unstructured":"Wolfe MS (2012) The role of tau in neurodegenerative diseases and its potential as a therapeutic target. Scientifica (Cairo) 2012:796024","journal-title":"Scientifica (Cairo)"},{"issue":"21","key":"821_CR113","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo C, Sun L, Chen X, Zhang D (2013) Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen Res 8(21):2003\u20132014","journal-title":"Neural Regen Res"},{"issue":"11","key":"821_CR114","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3390\/biom12111676","volume":"12","author":"Z Fi\u0161ar","year":"2022","unstructured":"Fi\u0161ar Z (2022) Linking the amyloid, tau, and mitochondrial hypotheses of Alzheimer\u2019s disease and identifying promising drug targets. Biomolecules 12(11):1676","journal-title":"Biomolecules"},{"issue":"1","key":"821_CR115","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1570159X17666190704153807","volume":"18","author":"M Rychlik","year":"2020","unstructured":"Rychlik M, Mlyniec K (2020) Zinc-mediated neurotransmission in Alzheimer\u2019s disease: a potential role of the GPR39 in dementia. Curr Neuropharmacol 18(1):2\u201313","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"821_CR116","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.3390\/antiox12111972","volume":"12","author":"P Lobos","year":"2023","unstructured":"Lobos P, Vega-V\u00e1squez I, Bruna B, Gleitze S, Toledo J, H\u00e4rtel S, Hidalgo C, Paula-Lima A (2023) Amyloid \u03b2-oligomers inhibit the nuclear Ca2+ signals and the neuroprotective gene expression induced by gabazine in hippocampal neurons. Antioxidants 12(11):1972","journal-title":"Antioxidants"},{"key":"821_CR117","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","volume":"14","author":"C Cheignon","year":"2018","unstructured":"Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer\u2019s disease. Redox Biol 14:450\u2013464","journal-title":"Redox Biol"},{"issue":"18","key":"821_CR118","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1021\/ic201233b","volume":"50","author":"F Bousejra-ElGarah","year":"2011","unstructured":"Bousejra-ElGarah F, Bijani C, Coppel Y, Faller P, Hureau C (2011) Iron(II) binding to amyloid-beta, the Alzheimer\u2019s peptide. Inorg Chem 50(18):9024\u20139030","journal-title":"Inorg Chem"},{"issue":"6","key":"821_CR119","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/psc.626","volume":"11","author":"FE Ali","year":"2005","unstructured":"Ali FE, Separovic F, Barrow CJ, Cherny RA, Fraser F, Bush AI, Masters CL, Barnham KJ (2005) Methionine regulates copper\/hydrogen peroxide oxidation products of Abeta. J Pept Sci 11(6):353\u2013360","journal-title":"J Pept Sci"},{"issue":"34","key":"821_CR120","doi-asserted-by":"publisher","first-page":"18680","DOI":"10.1002\/anie.202104497","volume":"60","author":"J Wu","year":"2021","unstructured":"Wu J, Blum TB, Farrell DP, DiMaio F, Abrahams JP, Luo J (2021) Cryo-electron microscopy imaging of alzheimer\u2019s amyloid-beta 42 oligomer displayed on a functionally and structurally relevant scaffold. Angew Chem Int Ed Engl 60(34):18680\u201318687","journal-title":"Angew Chem Int Ed Engl"},{"issue":"33","key":"821_CR121","doi-asserted-by":"publisher","first-page":"18340","DOI":"10.1021\/jacs.3c03980","volume":"145","author":"M Khaled","year":"2023","unstructured":"Khaled M, Ronnback I, Ilag LL, Graslund A, Strodel B, Osterlund N (2023) A hairpin motif in the amyloid-beta peptide is important for formation of disease-related oligomers. J Am Chem Soc 145(33):18340\u201318354","journal-title":"J Am Chem Soc"},{"issue":"5","key":"821_CR122","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/biomedicines11051398","volume":"11","author":"Y Ratan","year":"2023","unstructured":"Ratan Y, Rajput A, Maleysm S, Pareek A, Jain V, Pareek A, Kaur R, Singh G (2023) An insight into cellular and molecular mechanisms underlying the pathogenesis of neurodegeneration in Alzheimer\u2019s disease. Biomedicines 11(5):1398","journal-title":"Biomedicines"},{"issue":"4","key":"821_CR123","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.bbadis.2018.01.023","volume":"1864","author":"LM Vargas","year":"2018","unstructured":"Vargas LM, Cerpa W, Mu\u00f1oz FJ, Zanlungo S, Alvarez AR (2018) Amyloid-\u03b2 oligomers synaptotoxicity: the emerging role of EphA4\/c-Abl signaling in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1864(4):1148\u20131159","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"821_CR124","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","volume":"15","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener 15(1):40","journal-title":"Mol Neurodegener"},{"key":"821_CR125","doi-asserted-by":"publisher","first-page":"560375","DOI":"10.3389\/fendo.2020.560375","volume":"11","author":"J Berlanga-Acosta","year":"2020","unstructured":"Berlanga-Acosta J, Guillen-Nieto G, Rodriguez-Rodriguez N, Bringas-Vega ML, Garcia-Del-Barco-Herrera D, Berlanga-Saez JO, Garcia-Ojalvo A, Valdes-Sosa MJ, Valdes-Sosa PA (2020) Insulin resistance at the crossroad of alzheimer disease pathology: a review. Front Endocrinol (Lausanne) 11:560375","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"821_CR126","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3390\/biology11060943","volume":"11","author":"G Galizzi","year":"2022","unstructured":"Galizzi G, Di Carlo M (2022) Insulin and its key role for mitochondrial function\/dysfunction and quality control: a shared link between dysmetabolism and neurodegeneration. Biology 11(6):943","journal-title":"Biology"},{"issue":"21","key":"821_CR127","doi-asserted-by":"publisher","first-page":"18414","DOI":"10.1074\/jbc.M110.209718","volume":"286","author":"S Jimenez","year":"2011","unstructured":"Jimenez S, Torres M, Vizuete M, Sanchez-Varo R, Sanchez-Mejias E, Trujillo-Estrada L, Carmona-Cuenca I, Caballero C, Ruano D, Gutierrez A, Vitorica J (2011) Age-dependent accumulation of soluble amyloid beta (Abeta) oligomers reverses the neuroprotective effect of soluble amyloid precursor protein-alpha (sAPP(alpha)) by modulating phosphatidylinositol 3-kinase (PI3K)\/Akt-GSK-3beta pathway in Alzheimer mouse model. J Biol Chem 286(21):18414\u201318425","journal-title":"J Biol Chem"},{"issue":"2","key":"821_CR128","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1590\/1980-57642015DN92000003","volume":"9","author":"M Matioli","year":"2015","unstructured":"Matioli M, Nitrini R (2015) Mechanisms linking brain insulin resistance to Alzheimer\u2019s disease. Dement Neuropsychol 9(2):96\u2013102","journal-title":"Dement Neuropsychol"},{"issue":"1","key":"821_CR129","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/156720512799015037","volume":"9","author":"SM de la Monte","year":"2012","unstructured":"de la Monte SM (2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer\u2019s disease. Curr Alzheimer Res 9(1):35\u201366","journal-title":"Curr Alzheimer Res"},{"issue":"5","key":"821_CR130","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","volume":"1792","author":"WQ Zhao","year":"2009","unstructured":"Zhao WQ, Townsend M (2009) Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease. Biochim Biophys Acta 1792(5):482\u2013496","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"821_CR131","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1096\/fj.06-7703com","volume":"22","author":"WQ Zhao","year":"2008","unstructured":"Zhao WQ, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ, Krafft GA, Klein WL (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22(1):246\u2013260","journal-title":"FASEB J"},{"issue":"2","key":"821_CR132","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1172\/JCI64595","volume":"123","author":"FG De Felice","year":"2013","unstructured":"De Felice FG (2013) Alzheimer\u2019s disease and insulin resistance: translating basic science into clinical applications. J Clin Invest 123(2):531\u2013539","journal-title":"J Clin Invest"},{"key":"821_CR133","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnagi.2017.00118","volume":"9","author":"RJ Mullins","year":"2017","unstructured":"Mullins RJ, Diehl TC, Chia CW, Kapogiannis D (2017) Insulin resistance as a link between amyloid-beta and tau pathologies in Alzheimer\u2019s disease. Front Aging Neurosci 9:118","journal-title":"Front Aging Neurosci"},{"issue":"28","key":"821_CR134","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","volume":"29","author":"QL Ma","year":"2009","unstructured":"Ma QL, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ, Chen PP, Hudspeth B, Chen C, Zhao Y, Vinters HV, Frautschy SA, Cole GM (2009) Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29(28):9078\u20139089","journal-title":"J Neurosci"},{"key":"821_CR135","doi-asserted-by":"publisher","first-page":"564641","DOI":"10.3389\/fcell.2020.564641","volume":"8","author":"SY Chou","year":"2020","unstructured":"Chou SY, Chan L, Chung CC, Chiu JY, Hsieh YC, Hong CT (2020) Altered insulin receptor substrate 1 phosphorylation in blood neuron-derived extracellular vesicles from patients with Parkinson\u2019s disease. Front Cell Dev Biol 8:564641","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"821_CR136","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-021-00428-5","volume":"16","author":"H Querfurth","year":"2021","unstructured":"Querfurth H, Lee HK (2021) Mammalian\/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration. Mol Neurodegener 16(1):44","journal-title":"Mol Neurodegener"},{"issue":"6","key":"821_CR137","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","volume":"18","author":"MV Lourenco","year":"2013","unstructured":"Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF, Sathler LB, Brito-Moreira J, Amaral OB, Silva CA, Freitas-Correa L, Espirito-Santo S, Campello-Costa P, Houzel JC, Klein WL, Holscher C, Carvalheira JB, Silva AM, Velloso LA, Munoz DP, Ferreira ST, De Felice FG (2013) TNF-alpha mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer\u2019s beta-amyloid oligomers in mice and monkeys. Cell Metab 18(6):831\u2013843","journal-title":"Cell Metab"},{"issue":"11","key":"821_CR138","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK (2011) Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta 1813(11):1978\u20131986","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"821_CR139","first-page":"2319","volume":"53","author":"GM Nitulescu","year":"2018","unstructured":"Nitulescu GM, Van De Venter M, Nitulescu G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Gradinaru D, Tsatsakis A, Tsoukalas D, Spandidos DA, Margina D (2018) The Akt pathway in oncology therapy and beyond (Review). Int J Oncol 53(6):2319\u20132331","journal-title":"Int J Oncol"},{"key":"821_CR140","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-4419-1599-3_11","volume":"665","author":"M Cui","year":"2009","unstructured":"Cui M, Huang Y, Zhao Y, Zheng J (2009) New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder. Adv Exp Med Biol 665:143\u2013159","journal-title":"Adv Exp Med Biol"},{"issue":"1\u20132","key":"821_CR141","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neulet.2005.12.060","volume":"398","author":"CK Won","year":"2006","unstructured":"Won CK, Ji HH, Koh PO (2006) Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation. Neurosci Lett 398(1\u20132):39\u201343","journal-title":"Neurosci Lett"},{"issue":"4","key":"821_CR142","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3390\/cells10040721","volume":"10","author":"CL Sayas","year":"2021","unstructured":"Sayas CL, \u00c1vila J (2021) GSK-3 and tau: a key duet in Alzheimer\u2019s disease. Cells 10(4):721","journal-title":"Cells"},{"issue":"4","key":"821_CR143","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/BCJ20210777","volume":"479","author":"Z Cheng","year":"2022","unstructured":"Cheng Z (2022) FoxO transcription factors in mitochondrial homeostasis. Biochem J 479(4):525\u2013536","journal-title":"Biochem J"},{"issue":"16","key":"821_CR144","doi-asserted-by":"publisher","first-page":"8590","DOI":"10.3390\/ijms22168590","volume":"22","author":"M Khalid","year":"2021","unstructured":"Khalid M, Alkaabi J, Khan MA, Adem A (2021) Insulin signal transduction perturbations in insulin resistance. Int J Mol Sci 22(16):8590","journal-title":"Int J Mol Sci"},{"issue":"9","key":"821_CR145","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1128\/MCB.18.9.5457","volume":"18","author":"SA Summers","year":"1998","unstructured":"Summers SA, Garza LA, Zhou H, Birnbaum MJ (1998) Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18(9):5457\u20135464","journal-title":"Mol Cell Biol"},{"issue":"3","key":"821_CR146","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.neuron.2016.12.020","volume":"93","author":"G Ashrafi","year":"2017","unstructured":"Ashrafi G, Wu Z, Farrell RJ, Ryan TA (2017) GLUT4 mobilization supports energetic demands of active synapses. Neuron 93(3):606\u2013615","journal-title":"Neuron"},{"key":"821_CR147","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-biochem-060109-094246","volume":"81","author":"JS Bogan","year":"2012","unstructured":"Bogan JS (2012) Regulation of glucose transporter translocation in health and diabetes. Annu Rev Biochem 81:507\u2013532","journal-title":"Annu Rev Biochem"},{"key":"821_CR148","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mito.2014.09.005","volume":"18","author":"J Choi","year":"2014","unstructured":"Choi J, Ravipati A, Nimmagadda V, Schubert M, Castellani RJ, Russell JW (2014) Potential roles of PINK1 for increased PGC-1alpha-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes. Mitochondrion 18:41\u201348","journal-title":"Mitochondrion"},{"issue":"2","key":"821_CR149","doi-asserted-by":"publisher","first-page":"201","DOI":"10.14336\/AD.2015.1007","volume":"7","author":"IG Onyango","year":"2016","unstructured":"Onyango IG, Dennis J, Khan SM (2016) mitochondrial dysfunction in Alzheimer\u2019s disease and the rationale for bioenergetics based therapies. Aging Dis 7(2):201\u2013214","journal-title":"Aging Dis"},{"issue":"1","key":"821_CR150","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT (2022) Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener 11(1):3","journal-title":"Transl Neurodegener"},{"issue":"10","key":"821_CR151","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.2337\/db13-1817","volume":"63","author":"L Weissmann","year":"2014","unstructured":"Weissmann L, Quaresma PG, Santos AC, de Matos AH, Pascoal VD, Zanotto TM, Castro G, Guadagnini D, da Silva JM, Velloso LA, Bittencourt JC, Lopes-Cendes I, Saad MJ, Prada PO (2014) IKKepsilon is key to induction of insulin resistance in the hypothalamus, and its inhibition reverses obesity. Diabetes 63(10):3334\u20133345","journal-title":"Diabetes"},{"issue":"4","key":"821_CR152","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.3390\/ijms24043506","volume":"24","author":"JH Yoon","year":"2023","unstructured":"Yoon JH, Hwang J, Son SU, Choi J, You SW, Park H, Cha SY, Maeng S (2023) How can insulin resistance cause Alzheimer\u2019s disease? Int J Mol Sci 24(4):3506","journal-title":"Int J Mol Sci"},{"key":"821_CR153","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.2147\/DDDT.S173970","volume":"12","author":"SK Rad","year":"2018","unstructured":"Rad SK, Arya A, Karimian H, Madhavan P, Rizwan F, Koshy S, Prabhu G (2018) Mechanism involved in insulin resistance via accumulation of beta-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer\u2019s disease. Drug Des Devel Ther 12:3999\u20134021","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"821_CR154","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.3390\/ijms23094641","volume":"23","author":"M Michailidis","year":"2022","unstructured":"Michailidis M, Tata DA, Moraitou D, Kavvadas D, Karachrysafi S, Papamitsou T, Vareltzis P, Papaliagkas V (2022) Antidiabetic drugs in the treatment of Alzheimer\u2019s disease. Int J Mol Sci 23(9):4641","journal-title":"Int J Mol Sci"},{"issue":"14","key":"821_CR155","doi-asserted-by":"publisher","first-page":"11450","DOI":"10.3390\/ijms241411450","volume":"24","author":"KEK Mantik","year":"2023","unstructured":"Mantik KEK, Kim S, Gu B, Moon S, Kwak HB, Park DH, Kang JH (2023) Repositioning of anti-diabetic drugs against dementia: insight from molecular perspectives to clinical trials. Int J Mol Sci 24(14):11450","journal-title":"Int J Mol Sci"},{"key":"821_CR156","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Gupta D, Edison P (2023) Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res Rev 89:101979","journal-title":"Ageing Res Rev"},{"key":"821_CR157","doi-asserted-by":"publisher","first-page":"667874","DOI":"10.3389\/fphar.2021.667874","volume":"12","author":"Q Chen","year":"2021","unstructured":"Chen Q, Cao T, Li N, Zeng C, Zhang S, Wu X, Zhang B, Cai H (2021) Repurposing of anti-diabetic agents as a new opportunity to alleviate cognitive impairment in neurodegenerative and neuropsychiatric disorders. Front Pharmacol 12:667874","journal-title":"Front Pharmacol"},{"issue":"1","key":"821_CR158","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biomedicines12010099","volume":"12","author":"MA Adem","year":"2024","unstructured":"Adem MA, Decourt B, Sabbagh MN (2024) Pharmacological approaches using diabetic drugs repurposed for Alzheimer\u2019s disease. Biomedicines 12(1):99","journal-title":"Biomedicines"},{"issue":"1","key":"821_CR159","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41380-022-01792-4","volume":"28","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Edison P (2023) Incretin and insulin signaling as novel therapeutic targets for Alzheimer\u2019s and Parkinson\u2019s disease. Mol Psychiatry 28(1):217\u2013229","journal-title":"Mol Psychiatry"},{"issue":"6","key":"821_CR160","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.18632\/aging.101250","volume":"9","author":"JA McCubrey","year":"2017","unstructured":"McCubrey JA, Lertpiriyapong K, Steelman LS, Abrams SL, Yang LV, Murata RM, Rosalen PL, Scalisi A, Neri LM, Cocco L, Ratti S, Martelli AM, Laidler P, Dulinska-Litewka J, Rakus D, Gizak A, Lombardi P, Nicoletti F, Candido S, Libra M, Montalto G, Cervello M (2017) Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs. Aging (Albany NY) 9(6):1477\u20131536","journal-title":"Aging (Albany NY)"},{"key":"821_CR161","doi-asserted-by":"publisher","first-page":"764994","DOI":"10.3389\/fphar.2021.764994","volume":"12","author":"RY Cao","year":"2021","unstructured":"Cao RY, Zhang Y, Feng Z, Liu S, Liu Y, Zheng H, Yang J (2021) The effective role of natural product berberine in modulating oxidative stress and inflammation related atherosclerosis: novel insights into the gut-heart axis evidenced by genetic sequencing analysis. Front Pharmacol 12:764994","journal-title":"Front Pharmacol"},{"issue":"1","key":"821_CR162","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"821_CR163","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer\u2019s disease. J Cell Biol 217(2):459\u2013472","journal-title":"J Cell Biol"},{"issue":"3","key":"821_CR164","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nat Rev Neurol 17(3):157\u2013172","journal-title":"Nat Rev Neurol"},{"key":"821_CR165","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fncel.2018.00329","volume":"12","author":"BL Fiebich","year":"2018","unstructured":"Fiebich BL, Batista CRA, Saliba SW, Yousif NM, de Oliveira ACP (2018) Role of microglia TLRs in neurodegeneration. Front Cell Neurosci 12:329","journal-title":"Front Cell Neurosci"},{"key":"821_CR166","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3389\/fimmu.2019.01000","volume":"10","author":"S Azam","year":"2019","unstructured":"Azam S, Jakaria M, Kim IS, Kim J, Haque ME, Choi DK (2019) Regulation of toll-like receptor (TLR) signaling pathway by polyphenols in the treatment of age-linked neurodegenerative diseases: focus on TLR4 signaling. Front Immunol 10:1000","journal-title":"Front Immunol"},{"key":"821_CR167","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1742-2094-11-48","volume":"11","author":"D Doens","year":"2014","unstructured":"Doens D, Fernandez PL (2014) Microglia receptors and their implications in the response to amyloid beta for Alzheimer\u2019s disease pathogenesis. J Neuroinflammation 11:48","journal-title":"J Neuroinflammation"},{"key":"821_CR168","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.bbi.2020.10.007","volume":"91","author":"L Li","year":"2021","unstructured":"Li L, Acioglu C, Heary RF, Elkabes S (2021) Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun 91:740\u2013755","journal-title":"Brain Behav Immun"},{"issue":"1","key":"821_CR169","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2(1):17023","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"821_CR170","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.3390\/biomedicines11092587","volume":"11","author":"BS Sivamaruthi","year":"2023","unstructured":"Sivamaruthi BS, Raghani N, Chorawala M, Bhattacharya S, Prajapati BG, Elossaily GM, Chaiyasut C (2023) NF-\u03baB pathway and its inhibitors: a promising frontier in the management of Alzheimer\u2019s disease. Biomedicines 11(9):2587","journal-title":"Biomedicines"},{"key":"821_CR171","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"RH Shih","year":"2015","unstructured":"Shih RH, Wang CY, Yang CM (2015) NF-kappaB Signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"821_CR172","doi-asserted-by":"publisher","first-page":"5414297","DOI":"10.1155\/2017\/5414297","volume":"2017","author":"KA Chuang","year":"2017","unstructured":"Chuang KA, Li MH, Lin NH, Chang CH, Lu IH, Pan IH, Takahashi T, Perng MD, Wen SF (2017) Rhinacanthin C alleviates amyloid-\u03b2 fibrils\u2019 toxicity on neurons and attenuates neuroinflammation triggered by LPS, amyloid-\u03b2, and interferon-\u03b3 in glial cells. Oxid Med Cell Longev 2017(1):5414297","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"821_CR173","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40478-023-01526-9","volume":"11","author":"JM Lawrence","year":"2023","unstructured":"Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR (2023) Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathol Commun 11(1):42","journal-title":"Acta Neuropathol Commun"},{"key":"821_CR174","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1742-2094-5-7","volume":"5","author":"SS Shaftel","year":"2008","unstructured":"Shaftel SS, Griffin WS, O\u2019Banion MK (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5:7","journal-title":"J Neuroinflammation"},{"issue":"1","key":"821_CR175","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13024-023-00674-9","volume":"18","author":"G Terzioglu","year":"2023","unstructured":"Terzioglu G, Young-Pearse TL (2023) Microglial function, INPP5D\/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer\u2019s disease. Mol Neurodegener 18(1):89","journal-title":"Mol Neurodegener"},{"issue":"3","key":"821_CR176","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","volume":"83","author":"M Van Zeller","year":"2021","unstructured":"Van Zeller M, Dias D, Sebastiao AM, Valente CA (2021) NLRP3 inflammasome: a starring role in amyloid-beta- and tau-driven pathological events in Alzheimer\u2019s disease. J Alzheimers Dis 83(3):939\u2013961","journal-title":"J Alzheimers Dis"},{"issue":"13","key":"821_CR177","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20(13):3328","journal-title":"Int J Mol Sci"},{"issue":"11","key":"821_CR178","doi-asserted-by":"publisher","first-page":"e0167428","DOI":"10.1371\/journal.pone.0167428","volume":"11","author":"S Cermak","year":"2016","unstructured":"Cermak S, Kosicek M, Mladenovic-Djordjevic A, Smiljanic K, Kanazir S, Hecimovic S (2016) Loss of cathepsin B and L leads to lysosomal dysfunction, NPC-like cholesterol sequestration and accumulation of the key Alzheimer\u2019s proteins. PLoS ONE 11(11):e0167428","journal-title":"PLoS ONE"},{"issue":"2","key":"821_CR179","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s12035-013-8576-6","volume":"49","author":"A Pislar","year":"2014","unstructured":"Pislar A, Kos J (2014) Cysteine cathepsins in neurological disorders. Mol Neurobiol 49(2):1017\u20131030","journal-title":"Mol Neurobiol"},{"issue":"12","key":"821_CR180","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1212\/WNL.55.12.1828","volume":"55","author":"A Nagai","year":"2000","unstructured":"Nagai A, Murakawa Y, Terashima M, Shimode K, Umegae N, Takeuchi H, Kobayashi S (2000) Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology 55(12):1828\u20131832","journal-title":"Neurology"},{"issue":"3","key":"821_CR181","doi-asserted-by":"publisher","first-page":"a036400","DOI":"10.1101\/cshperspect.a036400","volume":"12","author":"S Xia","year":"2020","unstructured":"Xia S, Hollingsworth LR, Wu H (2020) Mechanism and regulation of gasdermin-mediated cell death. Cold Spring Harb Perspect Biol 12(3):a036400","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"821_CR182","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-1-4939-7519-8_9","volume":"1714","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Shi J, Shao F (2018) Inflammatory caspases: activation and cleavage of gasdermin-D in vitro and during pyroptosis. Methods Mol Biol 1714:131\u2013148","journal-title":"Methods Mol Biol"},{"key":"821_CR183","doi-asserted-by":"publisher","first-page":"896852","DOI":"10.3389\/fnagi.2022.896852","volume":"14","author":"YJ Xu","year":"2022","unstructured":"Xu YJ, Au NPB, Ma CHE (2022) Functional and phenotypic diversity of microglia: implication for microglia-based therapies for Alzheimer\u2019s disease. Front Aging Neurosci 14:896852","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"821_CR184","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska A, Keren-Shaul H, Weiner A, Colonna M, Schwartz M, Amit I (2018) Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173(5):1073\u20131081","journal-title":"Cell"},{"issue":"1","key":"821_CR185","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13024-023-00679-4","volume":"18","author":"A Sudwarts","year":"2023","unstructured":"Sudwarts A, Thinakaran G (2023) Alzheimer\u2019s genes in microglia: a risk worth investigating. Mol Neurodegener 18(1):90","journal-title":"Mol Neurodegener"},{"key":"821_CR186","doi-asserted-by":"publisher","first-page":"1034692","DOI":"10.3389\/fmed.2022.1034692","volume":"9","author":"AN Smith","year":"2022","unstructured":"Smith AN, Shaughness M, Collier S, Hopkins D, Byrnes KR (2022) Therapeutic targeting of microglia mediated oxidative stress after neurotrauma. Front Med (Lausanne) 9:1034692","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"821_CR187","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/antiox9080743","volume":"9","author":"DS Simpson","year":"2020","unstructured":"Simpson DS, Oliver PL (2020) ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants 9(8):743","journal-title":"Antioxidants"},{"issue":"18","key":"821_CR188","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.3390\/ijms21186676","volume":"21","author":"E Kim","year":"2020","unstructured":"Kim E, Otgontenger U, Jamsranjav A, Kim SS (2020) Deleterious alteration of glia in the brain of Alzheimer\u2019s disease. Int J Mol Sci 21(18):6676","journal-title":"Int J Mol Sci"},{"issue":"2","key":"821_CR189","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","volume":"66","author":"PT Francis","year":"1999","unstructured":"Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 66(2):137\u2013147","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"821_CR190","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27(6):1816","journal-title":"Molecules"},{"issue":"20","key":"821_CR191","doi-asserted-by":"publisher","first-page":"12092","DOI":"10.3390\/ijms232012092","volume":"23","author":"V Campos-Pe\u00f1a","year":"2022","unstructured":"Campos-Pe\u00f1a V, Pichardo-Rojas P, S\u00e1nchez-Barbosa T, Ort\u00edz-Islas E, Rodr\u00edguez-P\u00e9rez CE, Montes P, Ramos-Palacios G, Silva-Adaya D, Valencia-Quintana R, Cerna-Cortes JF, Toral-Rios D (2022) Amyloid \u03b2, lipid metabolism, basal cholinergic system, and therapeutics in Alzheimer\u2019s disease. Int J Mol Sci 23(20):12092","journal-title":"Int J Mol Sci"},{"issue":"18","key":"821_CR192","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.1111\/bph.14688","volume":"176","author":"E Cecon","year":"2019","unstructured":"Cecon E, Dam J, Luka M, Gautier C, Chollet AM, Delagrange P, Danober L, Jockers R (2019) Quantitative assessment of oligomeric amyloid beta peptide binding to alpha7 nicotinic receptor. Br J Pharmacol 176(18):3475\u20133488","journal-title":"Br J Pharmacol"},{"issue":"9","key":"821_CR193","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.3390\/molecules27092780","volume":"27","author":"K Takata","year":"2022","unstructured":"Takata K, Kimura H, Yanagisawa D, Harada K, Nishimura K, Kitamura Y, Shimohama S, Tooyama I (2022) Nicotinic acetylcholine receptors and microglia as therapeutic and imaging targets in Alzheimer\u2019s disease. Molecules 27(9):2780","journal-title":"Molecules"},{"issue":"1","key":"821_CR194","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/pharmaceutics15010031","volume":"15","author":"CH Lee","year":"2022","unstructured":"Lee CH, Hung SY (2022) Physiologic functions and therapeutic applications of \u03b17 nicotinic acetylcholine receptor in brain disorders. Pharmaceutics 15(1):31","journal-title":"Pharmaceutics"},{"key":"821_CR195","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbr.2014.07.046","volume":"274","author":"V Parikh","year":"2014","unstructured":"Parikh V, Bernard CS, Naughton SX, Yegla B (2014) Interactions between Abeta oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacities. Behav Brain Res 274:30\u201342","journal-title":"Behav Brain Res"},{"issue":"4","key":"821_CR196","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bcp.2015.07.015","volume":"97","author":"Q Cheng","year":"2015","unstructured":"Cheng Q, Yakel JL (2015) The effect of alpha7 nicotinic receptor activation on glutamatergic transmission in the hippocampus. Biochem Pharmacol 97(4):439\u2013444","journal-title":"Biochem Pharmacol"},{"key":"821_CR197","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fnins.2019.00043","volume":"13","author":"J Liu","year":"2019","unstructured":"Liu J, Chang L, Song Y, Li H, Wu Y (2019) The role of NMDA receptors in Alzheimer\u2019s disease. Front Neurosci 13:43","journal-title":"Front Neurosci"},{"issue":"4","key":"821_CR198","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bcp.2015.07.018","volume":"97","author":"F Koukouli","year":"2015","unstructured":"Koukouli F, Maskos U (2015) The multiple roles of the alpha7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system. Biochem Pharmacol 97(4):378\u2013387","journal-title":"Biochem Pharmacol"},{"key":"821_CR199","first-page":"e933978","volume":"28","author":"K Cao","year":"2022","unstructured":"Cao K, Xiang J, Dong YT, Xu Y, Guan ZZ (2022) Activation of alpha7 nicotinic acetylcholine receptor by its selective agonist improved learning and memory of amyloid precursor protein\/presenilin 1 (APP\/PS1) mice via the Nrf2\/HO-1 pathway. Med Sci Monit 28:e933978","journal-title":"Med Sci Monit"},{"issue":"6","key":"821_CR200","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/cells13060474","volume":"13","author":"\u00c9N Soares","year":"2024","unstructured":"Soares \u00c9N, Costa AC, Ferrolho GD, Ureshino RP, Getachew B, Costa SL, Da Silva VD, Tizabi Y (2024) Nicotinic acetylcholine receptors in glial cells as molecular target for Parkinson\u2019s disease. Cells 13(6):474","journal-title":"Cells"},{"issue":"11","key":"821_CR201","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/syn.20951","volume":"65","author":"SF Li","year":"2011","unstructured":"Li SF, Wu MN, Wang XH, Yuan L, Yang D, Qi JS (2011) Requirement of alpha7 nicotinic acetylcholine receptors for amyloid beta protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo. Synapse 65(11):1136\u20131143","journal-title":"Synapse"},{"issue":"1","key":"821_CR202","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","volume":"14","author":"TH Ferreira-Vieira","year":"2016","unstructured":"Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM (2016) Alzheimer\u2019s disease: targeting the cholinergic system. Curr Neuropharmacol 14(1):101\u2013115","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"821_CR203","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuroimage.2003.09.042","volume":"21","author":"K Herholz","year":"2004","unstructured":"Herholz K, Weisenbach S, Zundorf G, Lenz O, Schroder H, Bauer B, Kalbe E, Heiss WD (2004) In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease. Neuroimage 21(1):136\u2013143","journal-title":"Neuroimage"},{"issue":"Suppl 2","key":"821_CR204","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00002093-199501002-00005","volume":"9","author":"C Geula","year":"1995","unstructured":"Geula C, Mesulam MM (1995) Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis Assoc Disord 9(Suppl 2):23\u201328","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"821_CR205","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.nicl.2018.101612","volume":"21","author":"L Scheef","year":"2019","unstructured":"Scheef L, Grothe MJ, Koppara A, Daamen M, Boecker H, Biersack H, Schild HH, Wagner M, Teipel S, Jessen F (2019) Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD). Neuroimage Clin 21:101612","journal-title":"Neuroimage Clin"},{"issue":"16","key":"821_CR206","doi-asserted-by":"publisher","first-page":"5066","DOI":"10.3390\/molecules27165066","volume":"27","author":"G Di Natale","year":"2022","unstructured":"Di Natale G, Sabatino G, Sciacca MFM, Tosto R, Milardi D, Pappalardo G (2022) A\u03b2 and tau interact with metal ions, lipid membranes and peptide-based amyloid inhibitors: are these common features relevant in Alzheimer\u2019s disease? Molecules 27(16):5066","journal-title":"Molecules"},{"issue":"9","key":"821_CR207","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","volume":"38","author":"GF Chen","year":"2017","unstructured":"Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38(9):1205\u20131235","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"821_CR208","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","volume":"167","author":"W Danysz","year":"2012","unstructured":"Danysz W, Parsons CG (2012) Alzheimer\u2019s disease, beta-amyloid, glutamate, NMDA receptors and memantine\u2013searching for the connections. Br J Pharmacol 167(2):324\u2013352","journal-title":"Br J Pharmacol"},{"issue":"4","key":"821_CR209","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bcp.2014.01.015","volume":"88","author":"CR Overk","year":"2014","unstructured":"Overk CR, Masliah E (2014) Pathogenesis of synaptic degeneration in Alzheimer\u2019s disease and Lewy body disease. Biochem Pharmacol 88(4):508\u2013516","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"821_CR210","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/biomedicines10071743","volume":"10","author":"BA Gutierrez","year":"2022","unstructured":"Gutierrez BA, Limon A (2022) Synaptic disruption by soluble oligomers in patients with Alzheimer\u2019s and Parkinson\u2019s disease. Biomedicines 10(7):1743","journal-title":"Biomedicines"},{"issue":"4","key":"821_CR211","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/cells11040706","volume":"11","author":"AY Baev","year":"2022","unstructured":"Baev AY, Vinokurov AY, Novikova IN, Dremin VV, Potapova EV, Abramov AY (2022) Interaction of mitochondrial calcium and ROS in neurodegeneration. Cells 11(4):706","journal-title":"Cells"},{"issue":"1","key":"821_CR212","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.expneurol.2007.10.008","volume":"210","author":"K Parameshwaran","year":"2008","unstructured":"Parameshwaran K, Dhanasekaran M, Suppiramaniam V (2008) Amyloid beta peptides and glutamatergic synaptic dysregulation. Exp Neurol 210(1):7\u201313","journal-title":"Exp Neurol"},{"issue":"11","key":"821_CR213","doi-asserted-by":"publisher","first-page":"5991","DOI":"10.3390\/ijms22115991","volume":"22","author":"M Sciaccaluga","year":"2021","unstructured":"Sciaccaluga M, Megaro A, Bellomo G, Ruffolo G, Romoli M, Palma E, Costa C (2021) An unbalanced synaptic transmission: cause or consequence of the amyloid oligomers neurotoxicity? Int J Mol Sci 22(11):5991","journal-title":"Int J Mol Sci"},{"key":"821_CR214","doi-asserted-by":"publisher","first-page":"591563","DOI":"10.1155\/2015\/591563","volume":"2015","author":"B Pochwat","year":"2015","unstructured":"Pochwat B, Nowak G, Szewczyk B (2015) Relationship between zinc (Zn (2+) ) and glutamate receptors in the processes underlying neurodegeneration. Neural Plast 2015:591563","journal-title":"Neural Plast"},{"key":"821_CR215","doi-asserted-by":"publisher","first-page":"855752","DOI":"10.3389\/fnmol.2022.855752","volume":"15","author":"AG Mohanan","year":"2022","unstructured":"Mohanan AG, Gunasekaran S, Jacob RS, Omkumar RV (2022) Role of Ca(2+)\/Calmodulin-dependent protein kinase type II in mediating function and dysfunction at glutamatergic synapses. Front Mol Neurosci 15:855752","journal-title":"Front Mol Neurosci"},{"key":"821_CR216","doi-asserted-by":"publisher","first-page":"635880","DOI":"10.3389\/fnmol.2021.635880","volume":"14","author":"F Fagiani","year":"2021","unstructured":"Fagiani F, Lanni C, Racchi M, Govoni S (2021) (Dys)regulation of synaptic activity and neurotransmitter release by beta-amyloid: a look beyond Alzheimer\u2019s disease pathogenesis. Front Mol Neurosci 14:635880","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"821_CR217","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai S, Swarnkar S, Tota S, Nath C, Tyagi N (2016) Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies. Mol Neurobiol 53(1):648\u2013661","journal-title":"Mol Neurobiol"},{"issue":"795","key":"821_CR218","doi-asserted-by":"publisher","first-page":"eade5892","DOI":"10.1126\/scisignal.ade5892","volume":"16","author":"NL Rumian","year":"2023","unstructured":"Rumian NL, Freund RK, Dell\u2019Acqua ML, Coultrap SJ, Bayer KU (2023) Decreased nitrosylation of CaMKII causes aging-associated impairments in memory and synaptic plasticity in mice. Sci Signal 16(795):eade5892","journal-title":"Sci Signal"},{"issue":"3","key":"821_CR219","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3390\/ijms21030908","volume":"21","author":"S Pelucchi","year":"2020","unstructured":"Pelucchi S, Stringhi R, Marcello E (2020) Dendritic spines in Alzheimer\u2019s disease: how the actin cytoskeleton contributes to synaptic failure. Int J Mol Sci 21(3):908","journal-title":"Int J Mol Sci"},{"issue":"1","key":"821_CR220","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, Cao X, Chen Z, Liu D (2021) The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener 10(1):45","journal-title":"Transl Neurodegener"},{"issue":"s1","key":"821_CR221","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/JAD-179935","volume":"64","author":"W Gulisano","year":"2018","unstructured":"Gulisano W, Maugeri D, Baltrons MA, Fa M, Amato A, Palmeri A, D\u2019Adamio L, Grassi C, Devanand DP, Honig LS, Puzzo D, Arancio O (2018) Role of amyloid-beta and tau proteins in Alzheimer\u2019s disease: confuting the amyloid cascade. J Alzheimers Dis 64(s1):S611\u2013S631","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"821_CR222","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12974-021-02309-6","volume":"18","author":"SC Woodburn","year":"2021","unstructured":"Woodburn SC, Bollinger JL, Wohleb ES (2021) The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation 18(1):258","journal-title":"J Neuroinflammation"},{"issue":"12","key":"821_CR223","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/alz.12582","volume":"18","author":"AP Mecca","year":"2022","unstructured":"Mecca AP, O\u2019Dell RS, Sharp ES, Banks ER, Bartlett HH, Zhao W, Lipior S, Diepenbrock NG, Chen MK, Naganawa M, Toyonaga T (2022) Synaptic density and cognitive performance in Alzheimer\u2019s disease: a PET imaging study with [11C] UCB-J. Alzheimers Dement 18(12):2527\u201336","journal-title":"Alzheimers Dement"},{"issue":"10","key":"821_CR224","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.3390\/molecules25102303","volume":"25","author":"G Becker","year":"2020","unstructured":"Becker G, Dammicco S, Bahri MA, Salmon E (2020) The rise of synaptic density PET imaging. Molecules 25(10):2303","journal-title":"Molecules"},{"issue":"1","key":"821_CR225","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7555\/JBR.36.20220145","volume":"37","author":"M Yuan","year":"2022","unstructured":"Yuan M, Wang Y, Huang Z, Jing F, Qiao P, Zou Q, Li J, Cai Z (2022) Impaired autophagy in amyloid-beta pathology: a traditional review of recent Alzheimer\u2019s research. J Biomed Res 37(1):30\u201346","journal-title":"J Biomed Res"},{"key":"821_CR226","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1472-6882-14-88","volume":"14","author":"X Wang","year":"2014","unstructured":"Wang X, Kim JR, Lee SB, Kim YJ, Jung MY, Kwon HW, Ahn YJ (2014) Effects of curcuminoids identified in rhizomes of Curcuma longa on BACE-1 inhibitory and behavioral activity and lifespan of Alzheimer\u2019s disease drosophila models. BMC Complement Altern Med 14:88","journal-title":"BMC Complement Altern Med"},{"issue":"10","key":"821_CR227","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/WNR.0000000000000803","volume":"28","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zhao Y, Nan Y, Wang X, Chen Y, Wang S (2017) (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer\u2019s disease. NeuroReport 28(10):590\u2013597","journal-title":"NeuroReport"},{"issue":"1","key":"821_CR228","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2014.07.032","volume":"36","author":"CJ Cox","year":"2015","unstructured":"Cox CJ, Choudhry F, Peacey E, Perkinton MS, Richardson JC, Howlett DR, Lichtenthaler SF, Francis PT, Williams RJ (2015) Dietary (-)-epicatechin as a potent inhibitor of betagamma-secretase amyloid precursor protein processing. Neurobiol Aging 36(1):178\u2013187","journal-title":"Neurobiol Aging"},{"issue":"1","key":"821_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.48130\/FMR-2022-0002","volume":"2","author":"C Ruan","year":"2022","unstructured":"Ruan C, Kong J, He X, Hu B, Zeng X (2022) Interaction between polyphenols and amyloids: from the view of prevention of protein misfolding disorders related diseases. Food Mater Res 2(1):1\u201315","journal-title":"Food Mater Res"},{"key":"821_CR230","doi-asserted-by":"publisher","first-page":"104382","DOI":"10.1016\/j.bioorg.2020.104382","volume":"105","author":"T Chen","year":"2020","unstructured":"Chen T, Yang Y, Zhu S, Lu Y, Zhu L, Wang Y, Wang X (2020) Inhibition of Abeta aggregates in Alzheimer\u2019s disease by epigallocatechin and epicatechin-3-gallate from green tea. Bioorg Chem 105:104382","journal-title":"Bioorg Chem"},{"issue":"4","key":"821_CR231","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/molecules21040518","volume":"21","author":"R Libro","year":"2016","unstructured":"Libro R, Giacoppo S, Soundara Rajan T, Bramanti P, Mazzon E (2016) Natural phytochemicals in the treatment and prevention of dementia: an overview. Molecules 21(4):518","journal-title":"Molecules"},{"key":"821_CR232","doi-asserted-by":"publisher","first-page":"5288698","DOI":"10.1155\/2022\/5288698","volume":"2022","author":"L Yan","year":"2022","unstructured":"Yan L, Guo MS, Zhang Y, Yu L, Wu JM, Tang Y, Ai W, Zhu FD, Law BY, Chen Q, Yu CL, Wong VK, Li H, Li M, Zhou XG, Qin DL, Wu AG (2022) Dietary plant polyphenols as the potential drugs in neurodegenerative diseases: current evidence, advances, and opportunities. Oxid Med Cell Longev 2022:5288698","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"821_CR233","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.3390\/biom13081196","volume":"13","author":"V Chandrasekaran","year":"2023","unstructured":"Chandrasekaran V, Hediyal TA, Anand N, Kendaganna PH, Gorantla VR, Mahalakshmi AM, Ghanekar RK, Yang J, Sakharkar MK, Chidambaram SB (2023) Polyphenols, autophagy and neurodegenerative diseases: a review. Biomolecules 13(8):1196","journal-title":"Biomolecules"},{"key":"821_CR234","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/B978-0-323-91250-1.00006-9","volume":"75","author":"U Bhuyan","year":"2022","unstructured":"Bhuyan U, Handique JG (2022) Plant polyphenols as potent antioxidants: highlighting the mechanism of antioxidant activity and synthesis\/development of some polyphenol conjugates. Stud Nat Prod Chem 75:243\u2013266","journal-title":"Stud Nat Prod Chem"},{"key":"821_CR235","doi-asserted-by":"publisher","first-page":"806470","DOI":"10.3389\/fphar.2022.806470","volume":"13","author":"M Rudrapal","year":"2022","unstructured":"Rudrapal M, Khairnar SJ, Khan J, Dukhyil AB, Ansari MA, Alomary MN, Alshabrmi FM, Palai S, Deb PK, Devi R (2022) Dietary polyphenols and their role in oxidative stress-induced human diseases: insights into protective effects, antioxidant potentials and mechanism(s) of action. Front Pharmacol 13:806470","journal-title":"Front Pharmacol"},{"issue":"6","key":"821_CR236","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3390\/molecules14062202","volume":"14","author":"DM Pereira","year":"2009","unstructured":"Pereira DM, Valent\u00e3o P, Pereira JA, Andrade PB (2009) Phenolics: from chemistry to biology. Molecules 14(6):2202\u20132211","journal-title":"Molecules"},{"issue":"1","key":"821_CR237","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/molecules19010078","volume":"19","author":"A Kurek-Gorecka","year":"2013","unstructured":"Kurek-Gorecka A, Rzepecka-Stojko A, Gorecki M, Stojko J, Sosada M, Swierczek-Zieba G (2013) Structure and antioxidant activity of polyphenols derived from propolis. Molecules 19(1):78\u2013101","journal-title":"Molecules"},{"issue":"s1","key":"821_CR238","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.3233\/JAD-200185","volume":"82","author":"J Lakey-Beitia","year":"2021","unstructured":"Lakey-Beitia J, Burillo AM, La Penna G, Hegde ML, Rao KS (2021) Polyphenols as potential metal chelation compounds against Alzheimer\u2019s disease. J Alzheimers Dis 82(s1):S335\u2013S357","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"821_CR239","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.mam.2010.09.006","volume":"31","author":"CG Fraga","year":"2010","unstructured":"Fraga CG, Galleano M, Verstraeten SV, Oteiza PI (2010) Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med 31(6):435\u2013445","journal-title":"Mol Aspects Med"},{"issue":"7","key":"821_CR240","doi-asserted-by":"publisher","first-page":"e0134156","DOI":"10.1371\/journal.pone.0134156","volume":"10","author":"FA Badria","year":"2015","unstructured":"Badria FA, Ibrahim AS, Badria AF, Elmarakby AA (2015) Curcumin attenuates iron accumulation and oxidative stress in the liver and spleen of chronic iron-overloaded rats. PLoS ONE 10(7):e0134156","journal-title":"PLoS ONE"},{"issue":"6","key":"821_CR241","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s12640-022-00605-4","volume":"40","author":"MD Mostafa","year":"2022","unstructured":"Mostafa MD, ElKomy MA, Othman AI, Amer ME, El-Missiry MA (2022) Epigallocatechin-3-gallate enhances cognitive and memory performance and protects against brain injury in methionine-induced hyperhomocysteinemia through interdependent molecular pathways. Neurotox Res 40(6):2103\u20132116","journal-title":"Neurotox Res"},{"issue":"1","key":"821_CR242","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408690390826464","volume":"43","author":"JV Higdon","year":"2003","unstructured":"Higdon JV, Frei B (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43(1):89\u2013143","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"11","key":"821_CR243","doi-asserted-by":"publisher","first-page":"e1900400","DOI":"10.1002\/cbdv.201900400","volume":"16","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Jiang Z, Lu H, Xu Z, Tong R, Shi J, Jia G (2019) Recent advances of natural polyphenols activators for keap1-Nrf2 signaling pathway. Chem Biodivers 16(11):e1900400","journal-title":"Chem Biodivers"},{"key":"821_CR244","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401\u2013426","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"821_CR245","first-page":"116","volume":"20","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Farkhondeh T, Samarghandian S (2020) Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury. Curr Mol Med 20(2):116\u2013133","journal-title":"Curr Mol Med"},{"issue":"4","key":"821_CR246","doi-asserted-by":"publisher","first-page":"3748","DOI":"10.3390\/ijms24043748","volume":"24","author":"I Moratilla-Rivera","year":"2023","unstructured":"Moratilla-Rivera I, S\u00e1nchez M, Vald\u00e9s-Gonz\u00e1lez JA, G\u00f3mez-Serranillos MP (2023) Natural products as modulators of Nrf2 signaling pathway in neuroprotection. Int J Mol Sci 24(4):3748","journal-title":"Int J Mol Sci"},{"issue":"12","key":"821_CR247","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.3390\/antiox10121859","volume":"10","author":"M Thiruvengadam","year":"2021","unstructured":"Thiruvengadam M, Venkidasamy B, Subramanian U, Samynathan R, Ali Shariati M, Rebezov M, Girish S, Thangavel S, Dhanapal AR, Fedoseeva N, Lee J (2021) Bioactive compounds in oxidative stress-mediated diseases: targeting the NRF2\/ARE signaling pathway and epigenetic regulation. Antioxidants 10(12):1859","journal-title":"Antioxidants"},{"issue":"4","key":"821_CR248","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.7150\/ijbs.90982","volume":"20","author":"AA Mamun","year":"2024","unstructured":"Mamun AA, Shao C, Geng P, Wang S, Xiao J (2024) Polyphenols targeting NF-kappaB pathway in neurological disorders: what we know so far? Int J Biol Sci 20(4):1332\u20131355","journal-title":"Int J Biol Sci"},{"issue":"22","key":"821_CR249","doi-asserted-by":"publisher","first-page":"13886","DOI":"10.3390\/ijms232213886","volume":"23","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang K, Yan J, Zhou Q, Wang X (2022) Recent progress in research on mechanisms of action of natural products against Alzheimer\u2019s disease: dietary plant polyphenols. Int J Mol Sci 23(22):13886","journal-title":"Int J Mol Sci"},{"issue":"5","key":"821_CR250","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3945\/jn.112.169516","volume":"143","author":"L Rojanathammanee","year":"2013","unstructured":"Rojanathammanee L, Puig KL, Combs CK (2013) Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J Nutr 143(5):597\u2013605","journal-title":"J Nutr"},{"issue":"1\u20132","key":"821_CR251","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/ars.2006.8.99","volume":"8","author":"WS Jeong","year":"2006","unstructured":"Jeong WS, Jun M, Kong AN (2006) Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 8(1\u20132):99\u2013106","journal-title":"Antioxid Redox Signal"},{"issue":"12","key":"821_CR252","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.3390\/nu6126020","volume":"6","author":"AN Li","year":"2014","unstructured":"Li AN, Li S, Zhang YJ, Xu XR, Chen YM, Li HB (2014) Resources and biological activities of natural polyphenols. Nutrients 6(12):6020\u20136047","journal-title":"Nutrients"},{"key":"821_CR253","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","volume":"13","author":"M Miranda","year":"2019","unstructured":"Miranda M, Morici JF, Zanoni MB, Bekinschtein P (2019) Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci 13:363","journal-title":"Front Cell Neurosci"},{"key":"821_CR254","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.fct.2013.05.007","volume":"58","author":"N Cho","year":"2013","unstructured":"Cho N, Lee KY, Huh J, Choi JH, Yang H, Jeong EJ, Kim HP, Sung SH (2013) Cognitive-enhancing effects of Rhus verniciflua bark extract and its active flavonoids with neuroprotective and anti-inflammatory activities. Food Chem Toxicol 58:355\u2013361","journal-title":"Food Chem Toxicol"},{"key":"821_CR255","doi-asserted-by":"publisher","first-page":"937605","DOI":"10.1155\/2012\/937605","volume":"2012","author":"F Zhang","year":"2012","unstructured":"Zhang F, Wang YY, Liu H, Lu YF, Wu Q, Liu J, Shi JS (2012) Resveratrol produces neurotrophic effects on cultured dopaminergic neurons through prompting astroglial BDNF and GDNF release. Evid Based Complement Alternat Med 2012:937605","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"821_CR256","first-page":"223","volume":"15","author":"KA Wollen","year":"2010","unstructured":"Wollen KA (2010) Alzheimer\u2019s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Altern Med Rev 15(3):223\u2013244","journal-title":"Altern Med Rev"},{"key":"821_CR257","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fphar.2019.00778","volume":"10","author":"D Mango","year":"2019","unstructured":"Mango D, Saidi A, Cisale GY, Feligioni M, Corbo M, Nistico R (2019) Targeting synaptic plasticity in experimental models of Alzheimer\u2019s disease. Front Pharmacol 10:778","journal-title":"Front Pharmacol"},{"issue":"1","key":"821_CR258","doi-asserted-by":"publisher","first-page":"9651236","DOI":"10.1155\/2016\/9651236","volume":"23016","author":"GP Dias","year":"2016","unstructured":"Dias GP, Cocks G, do Nascimento Bevilaqua MC, Nardi AE, Thuret S (2016) Resveratrol: a potential hippocampal plasticity enhancer. Oxid Med Cell Longev 23016(1):9651236","journal-title":"Oxid Med Cell Longev"},{"issue":"21","key":"821_CR259","doi-asserted-by":"publisher","first-page":"14497","DOI":"10.1074\/jbc.M708373200","volume":"283","author":"SJ Kim","year":"2008","unstructured":"Kim SJ, Son TG, Park HR, Park M, Kim MS, Kim HS, Chung HY, Mattson MP, Lee J (2008) Curcumin stimulates proliferation of embryonic neural progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 283(21):14497\u201314505","journal-title":"J Biol Chem"},{"key":"821_CR260","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2007.05.071","volume":"1162","author":"Y Xu","year":"2007","unstructured":"Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO (2007) Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 1162:9\u201318","journal-title":"Brain Res"},{"issue":"1","key":"821_CR261","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.abb.2010.05.003","volume":"501","author":"S Chung","year":"2010","unstructured":"Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501(1):79\u201390","journal-title":"Arch Biochem Biophys"},{"key":"821_CR262","first-page":"100155","volume":"6","author":"FT Borsoi","year":"2023","unstructured":"Borsoi FT, Neri-Numa IA, de Oliveira WQ, de Araujo FF, Pastore GM (2023) Dietary polyphenols and their relationship to the modulation of non-communicable chronic diseases and epigenetic mechanisms: a mini-review. Food Chem (Oxf) 6:100155","journal-title":"Food Chem (Oxf)"},{"issue":"5","key":"821_CR263","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1002\/ptr.8176","volume":"38","author":"S Zhang","year":"2024","unstructured":"Zhang S, Kiarasi F (2024) Therapeutic effects of resveratrol on epigenetic mechanisms in age-related diseases: a comprehensive review. Phytother Res 38(5):2347\u20132360","journal-title":"Phytother Res"},{"issue":"25","key":"821_CR264","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1523\/JNEUROSCI.0364-08.2008","volume":"28","author":"J Wang","year":"2008","unstructured":"Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM (2008) Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer\u2019s disease. J Neurosci 28(25):6388\u20136392","journal-title":"J Neurosci"},{"issue":"17","key":"821_CR265","doi-asserted-by":"publisher","first-page":"21791","DOI":"10.18632\/aging.203482","volume":"13","author":"S Li","year":"2021","unstructured":"Li S, Wang C, Wang Z, Tan J (2021) Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer\u2019s disease: an adrenergic approach. Aging (Albany NY) 13(17):21791\u201321806","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"821_CR266","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.clnu.2020.08.025","volume":"40","author":"JJT Zaw","year":"2021","unstructured":"Zaw JJT, Howe PR, Wong RH (2021) Long-term effects of resveratrol on cognition, cerebrovascular function and cardio-metabolic markers in postmenopausal women: A 24-month randomised, double-blind, placebo-controlled, crossover study. Clin Nutr 40(3):820\u2013829","journal-title":"Clin Nutr"},{"issue":"2","key":"821_CR267","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/molecules26020415","volume":"26","author":"R Fukutomi","year":"2021","unstructured":"Fukutomi R, Ohishi T, Koyama Y, Pervin M, Nakamura Y, Isemura M (2021) Beneficial effects of epigallocatechin-3-O-gallate, chlorogenic acid, resveratrol, and curcumin on neurodegenerative diseases. Molecules 26(2):415","journal-title":"Molecules"},{"issue":"4","key":"821_CR268","first-page":"1276","volume":"14","author":"TY You","year":"2023","unstructured":"You TY, Dong Q, Cui M (2023) Emerging links between cerebral blood flow regulation and cognitive decline: a role for brain microvascular pericytes. Aging Dis 14(4):1276\u20131291","journal-title":"Aging Dis"},{"issue":"9","key":"821_CR269","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/molecules21091243","volume":"21","author":"G Mazzanti","year":"2016","unstructured":"Mazzanti G, Di Giacomo S (2016) Curcumin and resveratrol in the management of cognitive disorders: what is the clinical evidence? Molecules 21(9):1243","journal-title":"Molecules"},{"issue":"6","key":"821_CR270","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3945\/ajcn.2009.28641","volume":"91","author":"DO Kennedy","year":"2010","unstructured":"Kennedy DO, Wightman EL, Reay JL, Lietz G, Okello EJ, Wilde A, Haskell CF (2010) Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr 91(6):1590\u20131597","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"821_CR271","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1080\/10408398.2016.1259209","volume":"58","author":"M Murray","year":"2018","unstructured":"Murray M, Dordevic AL, Ryan L, Bonham MP (2018) An emerging trend in functional foods for the prevention of cardiovascular disease and diabetes: marine algal polyphenols. Crit Rev Food Sci Nutr 58(8):1342\u20131358","journal-title":"Crit Rev Food Sci Nutr"},{"key":"821_CR272","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.yfrne.2020.100857","volume":"59","author":"Z Huang","year":"2020","unstructured":"Huang Z, Wong LW, Su Y, Huang X, Wang N, Chen H, Yi C (2020) Blood-brain barrier integrity in the pathogenesis of Alzheimer\u2019s disease. Front Neuroendocrinol 59:100857","journal-title":"Front Neuroendocrinol"},{"issue":"2","key":"821_CR273","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/antiox11020197","volume":"11","author":"Y Kim","year":"2022","unstructured":"Kim Y, Cho AY, Kim HC, Ryu D, Jo SA, Jung YS (2022) Effects of natural polyphenols on oxidative stress-mediated blood-brain barrier dysfunction. Antioxidants 11(2):197","journal-title":"Antioxidants"},{"issue":"3","key":"821_CR274","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4103\/bc.bc_29_20","volume":"6","author":"S Yuan","year":"2020","unstructured":"Yuan S, Liu KJ, Qi Z (2020) Occludin regulation of blood-brain barrier and potential therapeutic target in ischemic stroke. Brain Circ 6(3):152\u2013162","journal-title":"Brain Circ"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00821-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-025-00821-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00821-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T05:02:24Z","timestamp":1769403744000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-025-00821-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":274,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["821"],"URL":"https:\/\/doi.org\/10.1007\/s10048-025-00821-y","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}